期刊文献+

Stealth核糖核苷酸干扰抑制胰腺癌细胞DNMT1表达的研究 被引量:1

Study of DNMT1 Stealth RNA Interference on the Expression of DNMTI Gene in the Pancreatic Cancer Cell Line
下载PDF
导出
摘要 目的:研究靶向甲基化转移酶1(DNMT1)基因的Stealth核糖核苷酸干扰(RNAi)技术对胰腺癌细胞Panc-1中DNMT1表达的抑制作用。方法:通过Block-IT TMRNAi Designer在线设计合成针对DNMT1的Stealth核糖核苷酸(siRNA),以50 nM siRNA用脂质体转染法转染Panc-1细胞。同时设空白对照组,RNAi阴性对照组,荧光RNAi组,每组3个复孔;在转染24 h、48 h、72 h后用荧光显微镜观察转染效率,以48 h荧光强度最亮。应用逆转录聚合酶链反应(RT-PCR)检测DMNT1信使核糖核酸(mRNA)含量,免疫印迹(Westem blot)检测DNMT1蛋白的表达。结果:将靶向DNMT1基因Stealth RNAi转染到胰腺癌细胞Panc-1中后,Panc-1细胞在转染RNAi后48 h的转染效率为50%~60%;DNMT1的蛋白和mRNA水平显著下调,与对照组相比,转染后48 h的相对抑制率分别为68%和67.8%(P<0.05),也显著低于空白对照组及空载体组(P<0.05)。结论:DNMT1靶向的Stealth RNA瞬时转染到胰腺癌细胞Panc-1中可显著沉默DNMT1的基因和蛋白的表达,为胰腺癌的基因治疗提供新的理论依据。 Objective:To investigate the suppression effect of the stealth RNAi targeting DNMT1 gene by transecting the pancreatic cancer cell line.Methods:The DNMT1-Stealth RNA was designed on line and synthesized by the Invitrogen Company.The Panc-1 cell line was transfected by the stealth RNAi in 50nM concentration of the lipofectamine 2000.The fluorescence of each group was observed under the microscope after 24 h,48 h and 72 h respectively.The expression of DNMT1 mRNA was detected by RT-PCR;the expression of DNMT1 protein was detected by Western blotting after transfected Stealth RNAi for 48 hours.Results:Forty-eight hours after the Panc-1 cell transfected by stealth RNAi,the efficiency of the transfection was between 50%to 60%.The expression of mRNA and protein of the 3^(rd) RNAi transfected group decreased 67.8%and 68%respectively comparing with the control(P 0.05).Conclusions: The RNAi targeting DNMT1 gene is transfected to the Panc-1 cell line,which could down regulated the DNMT1 gene expression both on mRNA and protein.This study provides a new gene therapy approach for pancreatic cancer management in the future.
出处 《中国临床医学》 2011年第6期757-760,共4页 Chinese Journal of Clinical Medicine
基金 博士后科学基金资助项目(编号:2005038379)
关键词 胰腺癌 RNA干扰 甲基化转移酶1 Pancreatic cancer RNA interfering(RNAi) DNA methyltransferasel(DNMT1)
  • 相关文献

参考文献1

二级参考文献2

共引文献4

同被引文献14

  • 1Ueki T,Toyota M,Skinner H. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma[J].Cancer Research,2001,(23):8540-8546.
  • 2Jiao L,Zhu J,Hassan M M. K-ras mutation and p16 and preproenkephalin promoter hypermethylation in plasma DNA of pancreatic cancer patients:in relation to cigarette smoking[J].Pancreas,2007,(01):55-62.
  • 3Peedicayil J. Epigenetic therapy-a new development in pharmacology[J].Indian Journal of Medical Research,2006,(01):17-24.
  • 4Baylin S B. Reversal of gene silencing as a therapeutic target for cancer-roles for DNA methylation and its interdigitation with chromatin[J].Novartis Foundation Symposium,2004.226-33,234-7,285-8.
  • 5Peng D F,Kanai Y,Sawada M. DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas[J].Carcinogenesis,2006,(06):1160-1168.doi:10.1093/carcin/bgi361.
  • 6Robert M F,Morin S,Beaulieu N. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells[J].Nature Genetics,2003.61-65.
  • 7Przybylski M,Kozowska A,Pietkiewicz P P. Increased CXCR4 expression in AsPC1 pancreatic carcinoma cells with RNA interference-mediated knockdown of DNMT1 and DNMT3B[J].Biomedicine and Pharmacotherapy,2010,(04):254-258.
  • 8Fukushima N,Walter K M,Uek T. Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice[J].Cancer Biology and Therapy,2003,(01):78-83.
  • 9Ohtsubo K,Watanabe H,Yao F. Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma[J].Journal of Gastroenterology,2006,(08):791-797.
  • 10Brune K,Hong S M,Li A. Genetic and epigenetic alterations of familial pancreatic cancers[J].Cancer Epidemiology Biomarkers and Prevention,2008,(12):3536-3542.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部